These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 5082272)
1. [Influence of particle size on tablet properties in manufacturing microcrystalline cellulose]. Hüttenrauch R; Jacob J; Zöbisch B Pharmazie; 1972 Jun; 27(6):416-7. PubMed ID: 5082272 [No Abstract] [Full Text] [Related]
2. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation. Dévay A; Mayer K; Pál S; Antal I J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480 [TBL] [Abstract][Full Text] [Related]
3. Particle size distribution and evolution in tablet structure during and after compaction. Fichtner F; Rasmuson A; Alderborn G Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568 [TBL] [Abstract][Full Text] [Related]
4. Benazepril hydrochloride: effects of particle size on tablet properties. Eyjolfsson R Pharmazie; 2006 Apr; 61(4):369-70. PubMed ID: 16649560 [TBL] [Abstract][Full Text] [Related]
5. Studies on direct compression of tablets. III. The effect on tablet strength of changes in particle shape and texture obtained by milling. Alderborn G; Nyström C Acta Pharm Suec; 1982; 19(2):147-56. PubMed ID: 7102353 [No Abstract] [Full Text] [Related]
6. [Progress in the manufacturing and control of tablets. XV. Mathematical interpretation of the pressure process]. Rak J; Chalabala M Cesk Farm; 1975 Mar; 24(2):84-91. PubMed ID: 1157104 [No Abstract] [Full Text] [Related]
7. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract]. Zgoda MM; Nachajski MJ; Kołodziejczyk MK Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170 [TBL] [Abstract][Full Text] [Related]
8. Improving flow properties of ibuprofen by fluidized bed particle thin-coating. Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403 [TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin polymer, a new tablet disintegrating agent. Fenyvest E; Antal B; Zsadon B; Szejtli J Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226 [TBL] [Abstract][Full Text] [Related]
10. Development of an oral rutin nanocrystal formulation. Mauludin R; Müller RH; Keck CM Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097 [TBL] [Abstract][Full Text] [Related]
11. Leveraging elevated temperature and particle size reduction to extract API from various tablet formulations. Nickerson B; Arikpo WB; Berry MR; Bobin VJ; Houck TL; Mansour HL; Warzeka J J Pharm Biomed Anal; 2008 Jun; 47(2):268-78. PubMed ID: 18280688 [TBL] [Abstract][Full Text] [Related]
12. Comparison of single pot and multiphase granulation. Part 1: Effect of the high shear granulator on granule properties according to the drug substance and its concentration. Giry K; Viana M; Genty M; Louvet F; Wüthrich P; Chulia D Pharm Dev Technol; 2009; 14(2):138-48. PubMed ID: 19519186 [TBL] [Abstract][Full Text] [Related]
13. The effect of mixing time of magnesium stearate on the tableting properties of dried microcrystalline cellulose. Khan KA; Musikabhumma P; Rubinstein MH Pharm Acta Helv; 1983; 58(4):109-11. PubMed ID: 6867042 [No Abstract] [Full Text] [Related]
14. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide. Takka S; Singh Bharaj S; Sakr A Pharmazie; 2003 Dec; 58(12):886-90. PubMed ID: 14703967 [TBL] [Abstract][Full Text] [Related]
15. Proceedings: The influence of fines on the flow and compaction properties of lactose. Fell JT J Pharm Pharmacol; 1973 Dec; 25():Suppl:109P. PubMed ID: 4150503 [No Abstract] [Full Text] [Related]
16. Evaluation of drug physical form during granulation, tabletting and storage. Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136 [TBL] [Abstract][Full Text] [Related]